{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:40:30Z","timestamp":1773150030521,"version":"3.50.1"},"reference-count":12,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1106.050471","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T19:27:03Z","timestamp":1331321223000},"page":"791-793","source":"Crossref","is-referenced-by-count":40,"title":["An Emptying Quiver: Antimicrobial Drugs and Resistance"],"prefix":"10.3201","volume":"11","author":[{"given":"J. Todd","family":"Weber","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Courvalin","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2005,6]]},"reference":[{"key":"key-10.3201\/eid1106.050471-201203090500-R1","unstructured":"Fleming A. Penicillin. Nobel lecture, December 11, 1945 [cited 2005 Mar 25]. Available from http:\/\/nobelprize.org\/medicine\/laureates\/1945\/fleming-lecture.pdf"},{"key":"key-10.3201\/eid1106.050471-201203090500-R2","unstructured":"Smolinski MS, Hamburg MA, Lederberg J, eds. Microbial threats to health: emergence, detection, and response. Washington: Institute of Medicine; 2003. p. 32"},{"key":"key-10.3201\/eid1106.050471-201203090500-R3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1465-0691.2004.1007.x","article-title":"Antimicrobial drug development\u2014the past, the present, and the future.","volume":"10","author":"Powers","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid1106.050471-201203090500-R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1465-0691.2004.1004.x","article-title":"The need for new antibiotics.","volume":"10","author":"Livermore","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid1106.050471-201203090500-R5","unstructured":"Food and Drug Administration. Linezolid approval [cited 2005 Apr 5]. Available from http:\/\/www.fda.gov\/cder\/foi\/appletter\/2000\/21130ltr.pdf"},{"key":"key-10.3201\/eid1106.050471-201203090500-R6","unstructured":"Food and Drug Administration. Daptomycin approval [cited 2005 Apr 5]. Available from http:\/\/www.fda.gov\/cder\/foi\/appletter\/2003\/21572ltr.pdf"},{"key":"key-10.3201\/eid1106.050471-201203090500-R7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.spid.2004.01.011","article-title":"Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine.","volume":"15","author":"Whitney","year":"2004","journal-title":"Semin Pediatr Infect Dis"},{"key":"key-10.3201\/eid1106.050471-201203090500-R8","unstructured":"Medicines for Malaria Venture. Available from http:\/\/www.mmv.org\/ [cited 2005 Apr 5]"},{"key":"key-10.3201\/eid1106.050471-201203090500-R9","unstructured":"Bloland PB. Drug resistance in malaria [cited 2005 Apr 5]. Geneva, Switzerland: World Health Organization; 2001. Available from http:\/\/www.who.int\/csr\/resources\/publications\/drugresist\/WHO_CDS_CSR_DRS_2001_4\/en\/"},{"key":"key-10.3201\/eid1106.050471-201203090500-R10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1086\/381546","article-title":"The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.","volume":"38","author":"Newman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1106.050471-201203090500-R11","first-page":"1052","article-title":"Notice to readers: discontinuation of cefixime tablets\u2014United States.","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1106.050471-201203090500-R12","first-page":"135","article-title":"Prevention and treatment of human immunodeficiency virus\/acquired immunodeficiency syndrome in resource-limited settings.","volume":"83","author":"Hogan","year":"2005","journal-title":"Bull World Health Organ"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/11\/6\/05-0471_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:04:47Z","timestamp":1732629887000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/11\/6\/05-0471_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1106.050471","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}